SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Shirakawa H, Kikuchi E, Tanaka N et al. Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer. BJU Int 2012 [Epub ahead of print]. DOI: 10.1111/j.1464-410X.2011.10894.x
  • 2
    Herr HW. Is maintenance Bacillus Calmette-Guérin really necessary? Eur Urol 2008; 54: 9713
  • 3
    Solsona E, Iborra I, Dumont R, Rubio-Briones J, Casanova J, Almenar S. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 2000; 164: 6859
  • 4
    Matsumoto K, Kikuchi E, Shirakawa H et al. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer. BJU Int 2012 [Epub ahead of print]. DOI: 10.1111/j.1464-410X.2012.11194.x
  • 5
    Raj GV, Herr H, Serio AM et al. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 2007; 177: 12836
  • 6
    van Rhijn BW, Burger M, Lotan Y et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 2009; 56: 4302